4 results
To establish the safety, tolerability, and early efficacy of multiple doses of hLF1-11 given once daily for 14 days.
In this study we want to investigate whether the submission of zoledronic acid to neoadjuvant chemotherapy benefits the pathological complete response, and thus favors a better clinical outcome in patients with large ressectable or locally advanced…
The main objective of the trial is to show that ABVD-based response-adapted therapy for advanced-stage Hodgkin lymphoma, with treatment intensification (BEACOPP) in case of a positive FDG-PET after one cycle of ABVD, has non-inferior efficacy…
Both the Supera and the Absolute Pro Stent System are self-expandable stents that are frequently used in regular clinic practice in patients with obstructive vascular disease. Results of both stent systems have been evaluated in several studies and…